KR960015891B1 - Lactococcus sp. bl1 and new bacteriocin, and processing of new bacteriocin - Google Patents

Lactococcus sp. bl1 and new bacteriocin, and processing of new bacteriocin Download PDF

Info

Publication number
KR960015891B1
KR960015891B1 KR1019930010815A KR930010815A KR960015891B1 KR 960015891 B1 KR960015891 B1 KR 960015891B1 KR 1019930010815 A KR1019930010815 A KR 1019930010815A KR 930010815 A KR930010815 A KR 930010815A KR 960015891 B1 KR960015891 B1 KR 960015891B1
Authority
KR
South Korea
Prior art keywords
antimicrobial
lactococcus
bacteria
kfcc
kofrijin
Prior art date
Application number
KR1019930010815A
Other languages
Korean (ko)
Other versions
KR950000867A (en
Inventor
유진영
정건섭
최신양
구영조
Original Assignee
한국식품개발연구원
서중일
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한국식품개발연구원, 서중일 filed Critical 한국식품개발연구원
Priority to KR1019930010815A priority Critical patent/KR960015891B1/en
Publication of KR950000867A publication Critical patent/KR950000867A/en
Application granted granted Critical
Publication of KR960015891B1 publication Critical patent/KR960015891B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46Streptococcus ; Enterococcus; Lactococcus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)

Abstract

The novel bacteriocin which is a kind of antibiotics, termed KOFRIJIN-1, is prepared by culturing Lactococcus SP. BL1(KFCC-10790), warming the culture media up in a double boiler, cooling, centrifuging, removing a precipitation, removing a precipitation 2-3 times after adding a solvent in the supernatant, dissolving an active fraction of a final precipitation in HCl solution, freeze-drying, and homogenizing to obtain the final product. The KOFRIJIN-1 shows a strong antibiotic effect to gram positive microorganisms, and don't shows any harmful effect to eukaryotes. Its titer is 2.2=G105IU/g and a molecular weight is 5,600 dalton.

Description

신규한 항균성물질(코프리진-I) 및 이를 생산하는 락토코커스 SP.BL1과 그의 제조방법Novel antimicrobial substance (Coprizine-I) and Lactococcus SP.BL1 to produce the same and method for producing the same

제1도는 본 발명 항균성물질(코프리진-I(KOFRIJIN-I))의 피검균(락토바실라스 프란타룸)에 대한 저해 정도를 나타낸 사진.Figure 1 is a photograph showing the degree of inhibition of the test bacteria (Lactobacillus plantarum) of the present invention antimicrobial material (KOFRIJIN-I).

제2도는 본 발명 항균성물질 생산균 락토코커스 SP.BL1(Lactococcus SP.BL1)의 현미경 사진이다.Figure 2 is a micrograph of the antibacterial substance producing bacterium Lactococcus SP.BL1 of the present invention.

본 발명은 신규한 항균성물질(이하 "코프리진-I(KOFRIJIN-I)"이라 칭함) 및 이를 생산하는 미생물 락토코커스 SP.BL1(Lactococcus SP.BL1)과 그의 제조방법에 관한 것이다.The present invention relates to a novel antimicrobial material (hereinafter referred to as "KOFRIJIN-I"), and microbial Lactococcus SP.BL1 (Lactococcus SP.BL1) for producing the same and a method for producing the same.

항균성물질의 일종인 단백질 형태의 박테리오신(Bacteriocin)은 비교적 독성이 적고 식품과 함께 섭취할 경우 여러 가지 단백질 분해효소에 의하여 쉽게 분해되어 식품보존재로서 광범위하게 이용되고 있는 실정이다.Bacteriocin in the form of protein, a kind of antimicrobial substance, is relatively low in toxicity and is easily decomposed by various proteolytic enzymes when ingested with food, and is widely used as a food preservative.

박테리오신은 여러 가지 세균에 의해 생산되는 것으로, 그 대부분이 저분자량의 단백질로 구성되어 있으며, 오직 유사한 종간에만 작용하는 것으로 알려져 있다.Bacteriocin is produced by a variety of bacteria, most of which are composed of low molecular weight proteins, and are known to act only on similar species.

최근까지 알려진 박테리오신(Bacteriocin)의 종류로는 콜리신스(colicins), 알바이신스(alveicins), 카토보리신스(cartovoricins), 아리조나신스(arizonacins), 클로아신스(cloacins), 말세신스(marcescins), 뉴모신스(pneumocins), 에로신스(aerocins), 파이오신스(pyocins), 후루오신스(fluocins), 메가신스(megacins), 모노신스(monocins), 세러신스(cerecins), 엔테로콕신(enterococcins), 스태필로콕신스(staphylococcins), 에피더미딘스(epidermidins) 등이 존재하며, 이러한 박테리오신들을 활성 스펙트럼으로 구별해보면 같은 과(科)의 균에 의하여 생산된 것이라도 상이한 형태의 물질을 생산하는 것으로 알려져 있다.The types of bacteriocins known until recently are colicins, alveicins, cartovoricins, arizonacins, cloacins, marcescins, nu Pneumocins, aerocins, pyocins, fluocins, megacins, monocins, cerecins, enterococcins, enterococcins Staphylococcins, epidermidins, etc. exist, and these bacteriocins are known to produce different types of substances even if they are produced by the same family of fungi.

상기한 항균성물질에 대한 저해 기능과 작용을 설명하면 첫 단계로 균체 표면에 있는 특이적인 수용체에 항균성물질 즉, 박테리오신이 흡착한 후 다음 단계로 박테리오신이 막을 침투하여 균체에 생화학적인 손상을 가함으로써 균체가 사멸하게 된다.Describing the inhibitory function and action of the above-mentioned antimicrobial substances, the first step is the adsorption of an antimicrobial substance, ie, bacteriocin, to a specific receptor on the surface of the cell. Will die.

이러한 박테리오신에 의한 균체의 손상은 두가지로 대별되며, 그중 하나는 세포내에 있는 DNA나 리보오좀(Ribosome)에 손상을 입히는 것으로, DNAse나 RNAse에 작용함으로써 DNA나 리보오좀(Ribosome)이 손상을 입히는 것이고, 균체에 손상을 가하는 다른 하나는 박테리오신이 직접 막에 손상을 가하는 것으로서, 고분자 합성의 저해, 칼륨 및 아미노산 등의 능동적 수송의 저해, ATP레벨의 저해 등이다.The bacteriocin-induced cell damage is classified into two types, one of which damages DNA or ribosomes in a cell, and damages DNA or ribosomes by acting on DNAse or RNAse. In addition, bacteriocins directly damage membranes, such as inhibiting polymer synthesis, inhibiting active transport of potassium and amino acids, and inhibiting ATP levels.

상기한 박테리오신은 여러 가지 균에 의하여 생산되는 것으로 밝혀져 있는데, 대표적인 항균성물질과 그 생산균은 표 1과 같다.The bacteriocin is found to be produced by a variety of bacteria, typical antimicrobial agents and their production are shown in Table 1.

[표-1 대표적인 항균성물질과 그 생산균]Table-1 Representative Antimicrobial Substances and Producing Bacteria

상술한 바와 같이, 박테리오신은 화학합성보존제를 대체할 수 있는 식품보존제로 사용될 수 있을 뿐만 아니라 소비자의 기피현상을 유발하지 않고 식품의 효과적인 저장성 향상을 기할 수 있지만 락토코커스속의 미생물로부터 생성되는 항균성 물질로는 니이신만이 공지되어 있는 실정이다.As described above, bacteriocin can be used as a food preservative that can replace chemical preservatives, and can be used as an antimicrobial substance produced by the microorganisms of the genus Lactococcus, although it can improve the effective shelf life of foods without causing the consumer to avoid. Ninisin is known only.

따라서, 본 발명의 목적은 단백질 분해효소에 의하여 쉽게 분해되어 식품보존제로서 이용가능한 항균성물질(코프리진-I(KOFRIJIN-I)) 및 이를 생산하는 락토코커스속 미생물과 그의 제조방법을 제공함에 있다.Accordingly, an object of the present invention is to provide an antimicrobial substance (coprizin-I (KOFRIJIN-I)) which can be easily degraded by proteolytic enzymes and used as a food preservative, and the Lactococcus microorganism producing the same and a method for producing the same.

상기 목적을 달성하기 위하여 본 발명에서는 자연계에서 식용젖산균을 분리하여 항균성물질을 생산하는 균주 락토코커스 SP.BL1(KFCC-10790)을 선별하고 이를 포도당과 카세인산 가수분해물을 주성분으로 하는 배지에서 배양한 후, 배양액을 용매법, 멤부레인 여과기법 및 동결건조법을 이용하여 분리, 정제하므로서 신규한 항균성물질(코프리진-I)을 고수율로 얻을 수 있었다.본 발명을 좀 더 구체적으로 설명하면 다음과 같다.In order to achieve the above object, in the present invention, strain Lactococcus SP.BL1 (KFCC-10790) which isolates edible lactic acid bacteria in nature and produces an antimicrobial substance was selected and cultured in a medium containing glucose and casein hydrolyzate as a main component. Thereafter, the culture solution was separated and purified using a solvent method, a membrane filter method, and a lyophilization method, thereby obtaining a new antimicrobial substance (coprizin-I) in high yield. Same as

[균주분리공정][Strain separation process]

공지의 방법에 의거하여 자연계로부터 항균성물질을 생산하는 균주를 분리하였다.Strains producing antimicrobial substances were isolated from nature based on known methods.

즉, 평판 배양법을 이용하여 시판 우유로부터 미생물을 순수 분리하고 항균력을 갖는 미생물을 선별한 다음, 락토바실러스 프란타룸 IFO 3070(ATCC 8014)를 피검균으로 하여 항균력이 우수한 미생물을 얻고, 이를 사단법인 한국종균협회에 기탁하였다(수탁번호 KFCC-10790).In other words, by using plate culture method, the microorganism is purely separated from commercial milk and the microorganism having antimicrobial activity is selected, and then Lactobacillus plantarum IFO 3070 (ATCC 8014) is used as a test bacterium to obtain microorganisms having excellent antimicrobial activity. Deposited to the spawn association (Accession No. KFCC-10790).

[항균성물질의 생산공정][Production process of antibacterial substance]

증류수 1ι에 원료로서 포도당 15∼25g, 카세인산가수분해물 12∼18g, 효모추출물 3∼7g, 구연산암모늄 1∼3g, 초산소다 1.5∼4.5g, 황산마그네슘 0.05∼0.2g, 인산카리 1∼3g, 황산망간 0.03∼0.07g을 잘 혼합하여 6.2정도의 pH가 되도록 하고 발효조에 넣는다. 이어 발효조의 온도를 110∼130℃로 하여 12∼18분간 살균한 다음 동 배지에 배양한 제2도에 나타낸 바와 같은 락토코커스 SP.BL1(사단법인 한국종균협회에 미생물 수탁번호 KFCC-10790으로서 기탁된 미생물)을 접종하고 30∼40℃에서 10∼14시간 동안 발효를 실시하여 항균성물질을 생성한다.15 to 25 g of glucose, 12 to 18 g of caseinate hydrolysate, 3 to 7 g of yeast extract, 1 to 3 g of ammonium citrate, 1.5 to 4.5 g of sodium acetate, 0.05 to 0.2 g of magnesium sulfate, 1 to 3 g of phosphate, Mix 0.03 to 0.07 g of manganese sulfate to a pH of 6.2 and add to fermenter. Subsequently, sterilization was performed at a temperature of 110 to 130 ° C. for 12 to 18 minutes, followed by deposit with Lactococcus SP.BL1 (microbial accession no. KFCC-10790 to the Korean spawn association) as shown in FIG. Microorganisms) are inoculated and fermented at 30 to 40 ° C. for 10 to 14 hours to produce an antimicrobial substance.

여기서 발효시간에 따른 항균성물질의 생산패턴은 표 2에 나타낸 바와 같다.Here, the production pattern of the antimicrobial material according to the fermentation time is shown in Table 2.

[표-2 락토코커스 SP.BL1에 의한 항균성물질의 생산패턴]Table 2 Production Pattern of Antimicrobial Agents by Lactococcus SP.BL1

표 2로부터 발효시간이 약 12시간 이상이면 항균성물질은 최대치인 3894IU/m의 역가를 나타냄을 알 수 있다.From Table 2 it can be seen that when the fermentation time is about 12 hours or more, the antimicrobial substance exhibits a titer of 3894 IU / m, which is the maximum.

[항균성물질의 분리 및 조제공정][Isolation and Preparation Process of Antibacterial Substances]

상기 항균성물질의 생산공정에서 발효가 종료된 발효액을 염산으로 pH 2 정도가 되도록 한 후 3∼7분간 중탕자비(重湯煮沸)하여 냉각시키고 5,500∼6,500rpm으로 10∼30분 원심분리하여 침전물을 제거함으로써 상등액을 만든다. 이어 상등액에다 상등액과 동일한 양의 메탄올을 넣어 생성되는 침전물을 제거하고, 또 상등액에 2배액 정도의 냉아세톤을 넣어 생성되는 침전물을 제거한 후 4배액 정도의 아세톤을 넣어 최종으로 침전물에 있는 활성분획을 취한다.In the production process of the antimicrobial material, the fermentation broth is finished to pH 2 with hydrochloric acid, and then cooled by boiling water for 3 to 7 minutes and centrifuged at 5,500 to 6,500 rpm for 10 to 30 minutes to remove the precipitate. By making a supernatant. Subsequently, the same amount of methanol as the supernatant was added to the supernatant to remove the precipitate, and 2 times the cold acetone was added to the supernatant to remove the formed precipitate, and then 4 times acetone was added to finally remove the active fraction in the precipitate. Take it.

다음에는 활성분획을 0.04∼0.06 노르말의 염산용액에 녹여 동결 건조한 후 분쇄하여 항균성물질을 얻는다.Next, the active fraction is dissolved in 0.04-0.06 normal hydrochloric acid solution, lyophilized and ground to obtain an antimicrobial substance.

이렇게 하여 얻어지는 항균성물질의 양은 발효액 1ι당 약 16∼17g(역가 2.2×155IU/g)을 얻을수 있다.The amount of antimicrobial material thus obtained can be obtained from about 16 to 17 g (titer 2.2 × 15 5 IU / g) per fermentation broth.

이하, 본 발명 항균성물질(코프리진-I(KOFRIJIN-I))의 제조방법을 실시예로서 상세하게 설명한다.Hereinafter, the manufacturing method of this invention antimicrobial substance (KOFRIJIN-I) is demonstrated in detail as an Example.

[실시예 1]Example 1

증류수 1ι에 포도당 20g, 카세인산 가수분해물 15g, 효모추출물 5g, 구연산암모늄 2g, 초산소다 3g, 황산마그네슘 0.1g, 인산카리 2g, 황산망간 0.05g을 잘 혼합하여 pH를 6.2가 되도록 하고 발효조에 넣었다.1 g of distilled water, 20 g of glucose, 15 g of caseinic acid hydrolyzate, 5 g of yeast extract, 2 g of ammonium citrate, 3 g of sodium acetate, 0.1 g of magnesium sulfate, 2 g of potassium phosphate, and 0.05 g of manganese sulfate were mixed to a pH of 6.2 and placed in a fermenter. .

다음에 발효조의 온도를 121℃가 되도록 하여 15분간 살균하고 동일한 배지에 18시간 배양한 락토코커스 SP.BL1(사단법인 한국종균협회에 미생물 수탁번호 KFCC-10790으로서 기탁된 미생물)을 접종하고 35℃에서 12시간 발효를 실시하여 항균성물질을 생산하였다.Next, the temperature of the fermenter was 121 ° C. and sterilized for 15 minutes, and inoculated with Lactococcus SP.BL1 (microorganisms deposited as microorganism accession no. KFCC-10790) at 35 ° C. incubated in the same medium for 18 hours. The fermentation was carried out at 12 hours to produce an antimicrobial substance.

[실시예 2]Example 2

실시예 1에서 발효가 종료된 발효액을 염산으로 pH가 2가 되도록 한 후 5분간 중탕자비(重湯煮沸)하고 냉각후 6,000rpm으로 20분간 원심분리하여 침전물을 제거하였다.The fermentation broth was fermented in Example 1 was adjusted to pH 2 with hydrochloric acid, and then bathed in boiling water for 5 minutes, and after cooling, the precipitate was removed by centrifugation at 6,000 rpm for 20 minutes.

다음에 상등액에 동량의 메탄올을 넣어 생성되는 침전물을 제거하고, 또 상등액에 상등액의 2배량의 아세톤을 넣어 최종으로 침전물을 제거하였다.Next, the same amount of methanol was added to the supernatant to remove the precipitate, and then, twice the amount of acetone was added to the supernatant to finally remove the precipitate.

이어 상등액에 상등액의 4배량의 아세톤을 넣어 최종적으로 침전물에 있는 활성분획을 얻었다.Subsequently, four times the amount of acetone of the supernatant was added to the supernatant to finally obtain an active fraction in the precipitate.

그 후에는 얻어진 활성분획을 0.05 노르말의 염산용액에 녹여 동결 건조한 후 분쇄하여 제1도에 나타낸 바와 같은 항균성물질인 코프리진-I(KOFRIJIN-I)를 얻었다.Thereafter, the obtained active fraction was dissolved in 0.05 normal hydrochloric acid solution, lyophilized, and ground to obtain Koprijin-I (KOFRIJIN-I), an antimicrobial substance as shown in FIG.

이렇게 하여 얻어지는 코프리진-I의 양은 발효액 1ι당 약 17g(역가 2.2×105IU/g)이었다.The amount of coprizin-I thus obtained was about 17 g (titer 2.2 × 10 5 IU / g) per fermentation broth.

[실시예 3]Example 3

실시예 1에서 얻어진 발효액을 염산 및 열처리로 전처리한 후 멤부레인 필터(Microsart 0.45㎛)로 여과하여 세포 파괴물을 제거하였다.The fermentation broth obtained in Example 1 was pretreated by hydrochloric acid and heat treatment, and then filtered through a membrane filter (Microsart 0.45 μm) to remove cell debris.

이어 여과액을 다시 멤부레인 필터(Ultrasart Cut-off=10,000 : 5,000)로 연속적으로 분별정제 후 동결 건조하여 최종 제품인 제1도에 나타낸 바와 같은 항균성물질 코프리진-I(KOFRIJIN-I)를 얻었다.Subsequently, the filtrate was continuously fractionated and purified by a membrane filter (Ultrasart Cut-off = 10,000: 5,000) and lyophilized to obtain an antimicrobial substance, Coprizin-I (KOFRIJIN-I) as shown in FIG. .

다음에는 단백질 형태의 항균성물질을 생산하는 생성균주와 항균성물질인 코프리진-I(KOFRIJIN-I)의 특성을 실험예로서 조사하였다.Next, the characteristics of the production strain producing the antimicrobial substance in the form of protein and the antimicrobial substance KOPRRIJ-I (KOFRIJIN-I) as an experimental example.

[실험예 1]Experimental Example 1

항균성물질을 생산하는 생성균주의 형태학적 및 생리적 특성을 검토한 결과 락토코커스 SP.BL1(사단법인 한국종균협회에 수탁번호 KFCC-10790으로서 기탁된 미생물)로 동정되었고 그 특성은 다음과 같았다.As a result of reviewing the morphological and physiological characteristics of the producing strain producing the antimicrobial substance, it was identified as Lactococcus SP.BL1 (microorganism deposited as KFCC-10790 with accession to the Korean spawn association).

[1. 형태학적 성질][One. Morphological properties]

락토코커스 SP.BL1의 균주는 쌍 또는 연쇄상 구균으로 한천배지 상에서 회백색 집락을 형성하며, 세포는 길게 늘어진 형태였고 그람염색 결과 양성이며, 운동성이 없었다.Strains of Lactococcus SP.BL1 form pairs or streptococci that form off-white colonies on agar media. Cells are elongated, positive for Gram staining, and lacking motility.

[2. 배양상의 제성질][2. Determination of Culture]

락토코커스 SP.BL1의 균주는 카탈레이스, 가스생성, 에스큐린분해, 아세토인 생성 음성, 혐기적 생육, 히퓨레이트 분해, 아니진 분해효소 양성을 나타내며 구체적으로 여러 가지 생화학적 또는 생리적 시험결과를 다음의 표 3과 같았다.Strains of Lactococcus SP.BL1 show catalase, gas production, escurin degradation, acetoin production negative, anaerobic growth, hypurate degradation, and anichinase positive. Specifically, the results of various biochemical or physiological tests Was shown in Table 3.

[표 3 항균성물질 생산균주 락토코커스 SP.BL1의 생화학적 시험결과][Table 3 Biochemical Test Results of Antibacterial Substances Producing Strain Lactococcus SP.BL1]

항균성물질 생산균주 락토코커스 SP.BL1은 생육전온이 35℃, 최적 pH 6.2이며, 약 9시간 후에 증식 정체기에 접어들며 포도당 배지에서 비저상 속도는 0.92H-1이고, 아미노산 요구성이 없으나 리보후라빈과 펜토텐산 요구성이 있음을 알았다.Lactococcus SP.BL1, the antimicrobial producing strain, has a growth temperature of 35 ° C and an optimal pH of 6.2, enters the growth plateau after about 9 hours, and has a non-base rate of 0.92H -1 in glucose medium. Lavin and pentothenic acid were found to be required.

[실험예 2]Experimental Example 2

항균성물질인 코프리진-I(KOFRIJIN-I)의 항균 스펙트럼을 조사한 결과는 표 4와 같았다.The antimicrobial spectrum of KOFRIJIN-I, an antimicrobial substance, was examined as shown in Table 4 below.

[표 4 항균성물질인 코프리진-I(KOFRIJIN-I)의 항균 스펙트럼]Table 4 Antimicrobial Spectra of Antibacterial Substance KOPRIZIN-I

+ : 저지환<10mm + + : 10-14.9mm+: Low ring <10mm + +: 10-14.9mm

+ + + : 15-19.9mm + + + + : >20mm+ + +: 15-19.9mm + + + +:> 20mm

표 4로부터 맹백한 바와 같이 코프리진-I 항균성물질은 마이크로코커스 류테우스와 같은 그람 양성균에 강력한 효력을 보일 뿐 아니라 에어로모나스 하이드로휠러 및 대장균 등 그람음성균에 약한 저해 효과를 주고 진핵세포에는 저해 효과가 없는 물질이다.As shown in Table 4, Coprizin-I antimicrobial agent not only shows a strong effect on Gram-positive bacteria such as Microcaucus luteus, but also has a weak inhibitory effect on Gram-negative bacteria such as Aeromonas hydrowheeler and Escherichia coli and inhibits on eukaryotic cells There is no substance.

[실험예 3]Experimental Example 3

코프리진-I 항균성물질의 효소 분해성과 pH 안전성을 조사하고 각각 표 5, 표 6으로 나타냈다.Enzyme degradability and pH safety of the coprizin-I antimicrobial were investigated and shown in Tables 5 and 6, respectively.

[표-5 코프리진-I(KOFRIJIN-I) 항균성물질의 효소 분해성]Table 5 Enzyme Degradability of KOFRIJIN-I Antimicrobial Substances

(-) : 활력소실, 효소역가 : 200단위/mg, 항균활력 : 2516단위/mg(-): Vitality loss, enzyme titer: 200 units / mg, antibacterial activity: 2516 units / mg

[표-6 코프리진-I(KOFRIJIN-I) 항균성물질의 pH 안전성]Table 6 pH Safety of KOFRIJIN-I Antimicrobial Substances

* 각 pH에서 처리후 25℃에서 2일후 조사한 잔존 활력임* Remaining vitality after 2 days at 25 ℃ after treatment at each pH

상기 표 5로부터 코프리진-I 항균성물질은 카복시 펩티다제와 프론아제, 프로테아제 IV 및 알파카이모트립신에 의하여 활력을 잃는 단백질 형태의 물질임을 알 수 있었고, 표 6으로부터 코프리진-I는 낮은 pH에서 안정한 항균성물질임을 알 수 있었다.It can be seen from Table 5 that the coprizin-I antimicrobial material is a protein form that loses its vitality by carboxy peptidase and pronase, protease IV and alpha chymotrypsin. It was found to be a stable antimicrobial material.

또한 코프리진-I는 100℃에서 60분간 가열할 때 60%가 실활되는 분자량 5,600달톤의 저분자량 물질이다.Coprizine-I is also a low molecular weight material with a molecular weight of 5,600 Daltons with 60% deactivation when heated at 100 ° C. for 60 minutes.

[실험예 4]Experimental Example 4

항균성물질인 코프리진-I(KOFRIJIN-I)의 아미노산 분석을 행하고 그 결과를 표 7에 기재하였다.Amino acid analysis of the antimicrobial substance koprijin-I (KOFRIJIN-I) was performed and the results are shown in Table 7.

즉, 실시예 2에서 얻은 코프리진-I 200mg에 6N HCl 20ml를 가하여 앰플(ampoule)에 넣고 질소가스로 충진시키면서 실링(Sealing)한 다음, 110℃에서 24시간 가수분해시켰다. 가수분해된 물질에 증류수를 100ml씩 3회 가하여 감압건조시켜 염산을 제거한 다음, 0.2N의 시트레이트 완충용액(pH 2.2) 5ml에 녹여 멤부레인 필터(0.22㎛ 공사이즈)를 통과시킨 후 아미노산 자동분석기(LKB4151, 알파플러스사제)에 주입하여 행하였다.That is, 20 ml of 6N HCl was added to 200 mg of coprizin-I obtained in Example 2, and the resulting mixture was sealed in an ampoule and filled with nitrogen gas, and then hydrolyzed at 110 ° C. for 24 hours. 100 ml of distilled water was added to the hydrolyzed substance three times, and dried under reduced pressure to remove hydrochloric acid. The solution was dissolved in 5 ml of 0.2 N citrate buffer (pH 2.2) and passed through a membrane filter (0.22 μm co-size). Injection was performed into an analyzer (LKB4151, manufactured by Alpha Plus).

[표 7 아미노산 조성]TABLE 7 Amino Acid Composition

상기 표 7로부터 알 수 있는 바와 같이, 본 발명의 코프리진-I는 전체 26개의 아미노산 잔기로 구성되어 있으며 니이신, 디플로코신 및 서브티린의 아미노산 구성과는 상이함을 보였고, 특히 이들에 비해 히스티딘의 함량이 월등히 많았다.As can be seen from Table 7, Coprizin-I of the present invention is composed of a total of 26 amino acid residues and has been shown to be different from the amino acid composition of nisin, diflocosin and subtyrin, in particular, Histidine content was much higher.

상기한 실시예 및 실험예에서 설명한 바와 같이 본 발명은 미생물로부터 용이하게 항균성물질을 생산할 수 있는 장점뿐만 아니라 항균성물질은 단백질 분해효소에 의하여 쉽게 분해됨으로써 식품보존제로서 활용할수 있는 효과가 있다.As described in the above Examples and Experimental Examples, the present invention not only has the advantage of easily producing antimicrobial substances from microorganisms, but also has an effect of being used as a food preservative by being easily degraded by proteolytic enzymes.

Claims (6)

쌍 또는 연쇄상 구균의 균주로서 한천배지 상에서 회백색 집락을 형성하고 그람염색 결과 양성이며, 운동성이 없고 아미노산 요구성은 없으나 리보후라빈과 펜토텐산 요구성이 있으며, 항균성물질의 생산능력을 갖는 사단법인 한국종균협회에 수탁번호 KFCC-10790으로서 기탁된 락토코커스 SP.BL1(Lactococcus SP.SL1).As a strain of Streptococcus or Streptococcus, it forms gray white colonies on agar medium and is positive for gram staining, has no mobility, no amino acid requirement, but needs riboflavin and pentothenic acid, and has the ability to produce antimicrobial agents. Lactococcus SP.BL1 deposited with the association accession number KFCC-10790. 그람양성균에 강력한 항균효과를 나타내면서 그람음성균에는 약한 항균효과를 나타내고 진핵세포에는 저해 효과가 없으며, 역가가 2.2×105IU/g이며, 분자량이 5,600달톤인 것으로, 한국종균협회에 수탁번호 KFCC-10790으로서 기탁된 락토코커스 SP.BL1(Lactococcus SP.SL1)부터 생성된 신규한 항균성물질.It has a strong antibacterial effect on Gram-positive bacteria, has a weak antimicrobial effect on Gram-negative bacteria, has no inhibitory effect on eukaryotic cells, has a titer of 2.2 × 10 5 IU / g and a molecular weight of 5,600 Daltons. Novel antimicrobial material produced from Lactococcus SP.SL1 deposited as 10790. 증류수에 주원료와 부원료를 혼합하여 발효조에 넣어 살균한 다음 동 배지에 락토코커스 SP.BL1균(수탁번호 KFCC-10790, 수탁기관 : 한국종균협회)을 접종하여 발효하고, 발효액을 중탕자비(重湯煮沸)하여 냉각후 원심분리로 침전물이 제거된 상등액을 만들며, 상등액에 용매를 넣어 생성되는 침전물을 2∼3회 제거하고, 최종 침전물에 있는 활성분획을 염산용액에 녹여 동결 건조 후 분쇄하는 것을 특징으로 하는 항균성물질 코프리진-I(KOFRIJIN-I)의 제조방법.Distilled water is mixed with main raw materials and subsidiary materials into a fermenter and sterilized. The medium is inoculated with Lactococcus SP.BL1 bacteria (Accession No. KFCC-10790, Trusted Authority: Korea spawn association) and fermented with fermented broth. After cooling, centrifugation to form a supernatant liquid from which the precipitate is removed, and a solvent is added to the supernatant solution to remove the produced precipitate two to three times, and the active fraction in the final precipitate is dissolved in hydrochloric acid solution and then lyophilized and ground. Method for producing an antimicrobial substance, coprizin-I (KOFRIJIN-I). 제3항에 있어서, 주원료가 포도당과 카세인산 가수분해 물질임을 특징으로 하는 항균성물질 코프리진-I의 제조방법.The method of claim 3, wherein the main raw material is glucose and caseinic acid hydrolyzate. 제3항에 있어서, 용매는 아세톤 및 메탄올임을 특징으로 하는 항균성물질 코프리진-I의 제조방법.The method of claim 3, wherein the solvent is acetone and methanol. 증류수에 주원료와 부원료를 혼합하여 발효조에 넣어 살균한 다음 동 배지에 락토코커스 SP.BL1균(수탁번호 KFCC-10790, 수탁기관 : 한국종균협회)을 접종하여 발효하고, 발효액을 염산 및 열처리로 전처리한 후 멤부레인 필터로 여과하여 세포 파괴물을 제거하고, 여과액을 다시 멤부레인 필터로 연속적으로 분별정제 후 동결 건조하여 제품화되는 것을 특징으로 하는 항균성물질 코프리진-I의 제조방법.Distilled water is mixed with main raw materials and subsidiary materials into a fermentation tank and sterilized, and then fermented by inoculating L. coccus sp.BL1 bacteria (Accession No. KFCC-10790, Trusted Organization: Korean Seed Association) on the medium, and fermentation broth is pretreated by hydrochloric acid and heat treatment. And then filtration through a membrane filter to remove cell debris, and the filtrate is subjected to filtration and freeze-drying continuously, followed by freeze-drying to produce the antimicrobial substance coprizin-I.
KR1019930010815A 1993-06-14 1993-06-14 Lactococcus sp. bl1 and new bacteriocin, and processing of new bacteriocin KR960015891B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019930010815A KR960015891B1 (en) 1993-06-14 1993-06-14 Lactococcus sp. bl1 and new bacteriocin, and processing of new bacteriocin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019930010815A KR960015891B1 (en) 1993-06-14 1993-06-14 Lactococcus sp. bl1 and new bacteriocin, and processing of new bacteriocin

Publications (2)

Publication Number Publication Date
KR950000867A KR950000867A (en) 1995-01-03
KR960015891B1 true KR960015891B1 (en) 1996-11-23

Family

ID=19357371

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930010815A KR960015891B1 (en) 1993-06-14 1993-06-14 Lactococcus sp. bl1 and new bacteriocin, and processing of new bacteriocin

Country Status (1)

Country Link
KR (1) KR960015891B1 (en)

Also Published As

Publication number Publication date
KR950000867A (en) 1995-01-03

Similar Documents

Publication Publication Date Title
US4746512A (en) Anticariogenic or antiperiodontitic agent
KR101399712B1 (en) Novel fermented milk product and use thereof
CN100379874C (en) Method for producing antibiotic peptide by using Bacillus amyloliquefaciens and product thereof
CN108148789B (en) Lactobacillus rhamnosus and application thereof in preparation of bacteriocin
CN110205266B (en) Lactobacillus paracasei capable of producing bacteriocin and application thereof
KR102176920B1 (en) Novel halophile Bacillus polyfermenticus producing halostable gamma-glutamyl transpeptidase
KR100413335B1 (en) Lactococcus lactis BH5(KCCM-10275) which is produced antimicrobial peptide
CN103667106B (en) A kind of plant lactobacillus, its bacteriocin and cultivation and separation purification method
CN113999793A (en) Lactobacillus plantarum with good fermentation characteristics and fragrance production function and screening method thereof
CN108432996B (en) Hericium erinaceus lactobacillus fermented beverage and preparation method thereof
RU2409661C2 (en) Enterococcus faecium lvp1073 strain, producer of bacteriocin against bacterial pathogens, bacteriocin e1073 against bacterial pathogens, lactobacillus plantarum 1 lvp7 strain - bacteriocin e1073 synthesis inducer, signal peptide sp1073 - bacteriocin e1073 synthesis regulator, method for producing bacteriocin e1073
KR102275530B1 (en) Composition for promoting growth of Lactic acid bacteria and a culture medium for Lactic acid bacteria
KR101156161B1 (en) Bacillus subtilis hj18-4 oligotrophic strain isolated from memil soksungjang and method for making fermentation food by using same
CN116218701A (en) Method for simultaneously producing class 2 antibacterial substances by bacillus bailii 1-3 and strain, antibacterial substances produced by same and application of antibacterial substances
KR960015891B1 (en) Lactococcus sp. bl1 and new bacteriocin, and processing of new bacteriocin
JPH0515366A (en) Proliferation promoter for lactic acid bacterium and bifidobacterium
CN100406551C (en) Leaven for fermenting meat product and its special-purpose strain
KR100273742B1 (en) Lactococcus lactis microorganism producing natural antibacterial substances (KFCC 11047)
Al-Taie et al. Optimization, purification, and characterization of enterocin SH1 produced by E. faecium SH1 and enterocin SH2 produced by E. faecalis SH2 isolated from dental caries
Vaidya et al. Evaluation of bacteriocin purified from potent lysinibacillussphaericus mk788143 isolated from infant faecal
Faridah et al. Characterization of extracellular protease from halophilic microbes isolated from Bledug Kuwu, Grobogan, Central Java
JP2010246398A (en) New antibacterial peptide
KR20080025795A (en) Lactobacillus paraplantarum knuc25 derived from kimchi having anti-bacterial activity and culture fluids thereof
EP3922309A1 (en) Novel lactococcus lactis strain for the production of bioactive compounds having antimicrobial effect
JP3783187B2 (en) Novel Lactobacillus lactic acid bacteria and cultures thereof

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20001123

Year of fee payment: 5

LAPS Lapse due to unpaid annual fee